COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series

Milos Jesenak, Peter Banovcin, Zuzana Diamant

Research output: Contribution to journalLetterpeer-review

Abstract

Currently, the world is facinga global pandemicwith a new coronavirus SARS-CoV- 2 (Severe Acute Respiratory Syndrome CoronaVirus Type 2) causing infectious disease named COVID-19 (CoronaVirus Infectious Disease 2019). Comparing the clinical presentation and epidemiological characteristics of COVID-19 with previous coronavirus-associated respiratory diseases (SARS-CoV1 and MERS) revealedsome remarkable findings and differences. Moreover, the clinical course of SARS-CoV-2 infection showed the complexity of COVID-19 profile with the variable clinical presentations.

Original languageEnglish
Pages (from-to)1819-1822
Number of pages4
JournalAllergy
Volume75
Issue number7
Early online date2020 May 5
DOIs
Publication statusPublished - 2020 Jul

Subject classification (UKÄ)

  • Infectious Medicine

Fingerprint

Dive into the research topics of 'COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series'. Together they form a unique fingerprint.

Cite this